Skip to main content
Equibles
CRL logo

CRL · Charles River Laboratories International, Inc.

Track CRL — free

Use CRL with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$293.35 +1.59 (+0.54%) At close · Sep 3
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$13.93B
Shares
47.74M

CRL metrics

74 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$293.35
Market cap
$13.93B

Price action

19 metrics
Price change (1W)
-1.1%
Price change (30D)
+24.6%
Price change (3M)
+62.2%
Price change (6M)
+62.5%
Price change (YTD)
+46.3%
Price change (1Y)
+80.9%
Trailing year
Price change (5Y)
-35.0%
52-week high
$298.58
52-week low
$145.57
Change from 52-week high
-2.3%
Change from 52-week low
+100.4%
Annualized volatility
45.8%
Beta
1.3
RSI (14D)
64.1
Price vs SMA 50
+16.1%
Price vs SMA 200
+46.7%
Avg volume (3M)
883,409
Relative volume
0.7
Average dollar volume
$211.76M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
47.74M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.5×
reciprocal yield 28.7%
P / book
4.9
reciprocal yield 20.4%
FCF yield
2.7%
TTM · current market cap
Buyback yield
2.3%
P / FCF
37.6
reciprocal yield 2.7%
P / operating cash flow
23.9
reciprocal yield 4.2%
Earnings yield
-1.7%

Historical valuation

8 metrics
P / E historical average (3Y)
91.4×
reciprocal yield 1.1%
P / E historical average (5Y)
71.9×
reciprocal yield 1.4%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
2.3%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
—
Operating margin
2.3%
Trailing 12 months
Net margin
-6.0%
Gross profit (TTM)
$1.07B
Operating profit (TTM)
$90.14M
Net income (TTM)
−$238.46M
Trailing 12 months
Diluted EPS (TTM)
$-4.80
FCF margin
9.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.01

Growth

11 metrics
Revenue growth YoY
-2.7%
Year over year
Net income growth YoY
-102.8%
Revenue (TTM)
$4.00B
Trailing 12 months
EPS growth YoY
-102.8%
Shares change YoY
-2.6%
Year over year · fewer shares
Revenue CAGR (3Y)
+0.3%
Revenue CAGR (5Y)
+6.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+20.7%
FCF CAGR (5Y)
+6.4%

Quality

14 metrics
Return on equity
-8.4%
Return on assets
-3.2%
Debt / equity
—
Current ratio
1.3
EBITDA (TTM)
$388.03M
Free cash flow (TTM)
$370.61M
Quick ratio
1.0
Interest coverage
0.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$192.03M
Total assets
$7.53B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$582.15M
Capital expenditures (TTM)
$211.54M
R&D (TTM)
—
SG&A (TTM)
$762.04M
Stock compensation (TTM)
$83.06M
R&D / revenue
—
Stock compensation / revenue
2.1%

Ownership (13F)

3 metrics
13F filers
571
13F filer change QoQ
+6
Institutional ownership
119.7%

Short interest

3 metrics
Short interest
4.9%
Latest settlement · 2.2 days to cover
Days to cover
2.2d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$42.61M
Insider-sentiment score
24 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1100682 CUSIP 159864107 13F (30d) 384 filings 376 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)